Recurring Ovarian Cancer Project REF CU00608

Ovarian Cancer remains a very difficult cancer to treat. Researchers at Curtin University are looking at the role the immune system has in cancer treatment for ovarian cancer.  They are looking for two consumer representatives to have input into a grant application for the project. 

Applications close: AS SOON AS POSSIBLE

About the project

Patients with ovarian cancer often face major surgery and/or chemotherapy to treat their conditions. Even still their cancer returns.

There is a demonstrated relationship between the role of the immune system and returning cancers.  Identifying these immune signs may help to identify why some patients achieve a long remission after chemotherapy and others don't.

This project aims to develop blood tests to predict long-term effectiveness of chemotherapy. 

About the position

We are looking for two consumer representatives who have been affected by recurring ovarian cancer or secondary cancer, to have input into the research and provide advice on a grant application. 

What am I expected to do? 

  • Provide a consumer perspective of living with recurring ovarian cancer
  • Provide feedback on grant application

When are meetings held?

Initially consumers are asked to meet with researcher to provide input into the grant application; this will only take a couple of hours. 

How long am I expected to be involved?

If this project receives funding – ongoing involvement will be for 2 years with meetings planned every 6 months.

Where will meetings be held?

Meetings can be held at Curtin University or another mutually agreeable venue.

What support is offered?

An honorarium of $30 per hour is offered. Training is available from the Consumer and Community Health Research Network.

Applications close: as soon as possible